Elevance Health, Inc.
ELVCIK 0001156039
Revenue (TTM)
$199.56B
+12.5% YoY
Q1 Apr 2026
Net Income (TTM)
$6.88B
−5.3% YoY
Q1 Apr 2026
EPS Diluted (TTM)
$30.65
−1.8% YoY
Q1 Apr 2026
Gross Margin
89.4%
Q1 Apr 2026
Operating Margin
4.5%
Q1 Apr 2026
Net Margin
3.4%
Q1 Apr 2026
Free Cash Flow (TTM)
$12.79B
Q1 Apr 2026
Cash
$9.66B
Q1 Apr 2026
Total Debt
$31.49B
Q1 Apr 2026
Shares Outstanding
217.16M sh
Q1 Apr 2026